HAVRIX 1440 [iU]/mL
Hepatitis A Vaccine · INJECTION, SUSPENSION · GlaxoSmithKline Biologicals SA
No Recall History
Plain English
HAVRIX is a injection, suspension containing hepatitis a vaccine at 1440 [iU]/mL, taken intramuscular. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- HAVRIX
- Generic Name
- Hepatitis A Vaccine
- NDC Code (Product)
58160-826- Manufacturer
- GlaxoSmithKline Biologicals SA
- Strength
- 1440 [iU]/mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103475
- Marketing Start
- 04/13/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is HAVRIX used for?
HAVRIX contains Hepatitis A Vaccine. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is HAVRIX a controlled substance?
HAVRIX is not classified as a controlled substance by the DEA.
What is the generic name for HAVRIX?
The generic name for HAVRIX is Hepatitis A Vaccine. There are 4 other brand versions of Hepatitis A Vaccine.
What is the NDC code for HAVRIX 1440 [iU]/mL?
The NDC (National Drug Code) for HAVRIX 1440 [iU]/mL is 58160-826, listed by GlaxoSmithKline Biologicals SA.